COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review.

COVID-19 children coronavirus inflammation pathogenic risk factors

Journal

Current pediatric reviews
ISSN: 1875-6336
Titre abrégé: Curr Pediatr Rev
Pays: United Arab Emirates
ID NLM: 101240290

Informations de publication

Date de publication:
2021
Historique:
received: 14 05 2020
revised: 06 10 2020
accepted: 08 10 2020
pubmed: 14 11 2020
medline: 17 4 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

This paper examines the potential link between COVID-19 and the presence of comorbidities and assesses the role of inflammation in this correlation. In COVID-19 patients, the most frequently associated diseases share a pathogenic inflammatory basis and apparently act as a risk factor in the onset of a more severe form of the disease, particularly in adulthood. However, in children, the understanding of the underlying pathogenic mechanisms is often complicated by the milder symptoms presented. A series of theories have, therefore, been put forward with a view of providing a better understanding of the role played by inflammation in this dramatic setting. All evidence available to date on this topic is discussed in this review.

Identifiants

pubmed: 33183207
pii: CPR-EPUB-111442
doi: 10.2174/1573396316666201112093920
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-44

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Giulia Pinna (G)

Neonatal Intensive Care Unit, University of Cagliari, Cagliari, Italy.

Lavinia Sanfilippo (L)

Neonatal Intensive Care Unit, University of Cagliari, Cagliari, Italy.

Pier Paolo Bassareo (PP)

University College of Dublin, Mater Misericordiae University Hospital and Our Lady's Children's Hospital Crumlin, Dublin, Ireland.

Vassilios Fanos (V)

Neonatal Intensive Care Unit, University of Cagliari, Cagliari, Italy.

Maria Antonietta Marcialis (MA)

Neonatal Intensive Care Unit, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH